Expanded Program On Immunization

Expanded Program on Immunization

Background and Definition

Expanded Program on Immunization (EPI), established in 1987, aimes at guaranteeing the right of every child in Lebanon, regardless of social status or parent's education level, on immunization and protection from diseases that have available effective and safe vaccines. In order to ensure that, the Ministry of Public Health guarantees the provision of vaccines in 700 health care centers, public and social, in collaboration with the private sector and with the conitnuous awareness of care givers about the importance of immunization. The program provides further special attention to chidlren residing in remote and underprivileged areas through quality outreach activities.

EPI ِAims at:

Elevating routine vaccination coverage per district to above 95%.
Preserving Lebanon as polio-free, considering the continuous influx of Syrian refugees and in preparation to the eradication of polio in the region and worldwide.
Eradicating Measles and Rubella by the end of year 2018.

EPI Activities:

Continuous training and capacity building throughout the year for health care workers on routine vaccination management and implementation in all districs.
Continuous work to keep Lebanon certified polio-free
Implementation of the RED STRATEGY to reach every child, which includes:
1. Data on the immunization coverage for children under one year of age
2. Data on immunization coverage in Lebanon
3. Identification of the number of drop-outs and planning to ensure their vaccination per district accordingly
Celebrating World Immunization Week and planning awareness sessions over Lebanon about routine vaccination
Conducting National and Mop-Up Immunization campaigns annually, including vaccination against Measles, Rubella, and Mumps
Conducting regular visits by the self-assessment team to follow on the quality of vaccination delivery service
Continuous collaboration with UNICEFand WHO to follow-up on updates related to immunization worldwide and ensuring implementation in Lebanon considering national and international commitments
Continuous collaboration with the private sector (General Practictioners and Pediatricians) to ensure vaccination for all children in Lebanon, particularly during immunization campaigns and routine immunization.

...

195

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01CD02	DOCETAXEL EBEWE	G	Docetaxel - 80mg/8ml	80mg/8ml	Injectable solution	L.L
A03BB01	HISCOPINE (HYOSCINE BUTYL BROMIDE INJECTION)	G	Hyoscine butylbromide - 20mg/ml	20mg/ml	Injectable solution	3,217,159 L.L
B05AA01	ALBUREL HUMAN ALBUMIN BP	BioHuman	Albumin human - 20%	20%	Injectable solution	6,353,687 L.L
B05XA03	SERUFLEX SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	163,184 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 200mg	200mg	Injectable solution	123,001,362 L.L
L03AB07	REBIF	BioTech	Interferon beta-1a - 44mcg/0.5ml	12MIU	Injectable solution	82,479,505 L.L
N01BB58	SEPTANEST ADRENALINEE	B	Articaine HCl - 72mg/1.8ml, Adrenaline (tartrate) - 0.033mg/1.8ml	1/100,000	Injectable solution	2,945,703 L.L
N05CD08	MIDAZOLAM NORMON.	G	Midazolam - 5mg/5ml	5mg/5ml	Injectable solution	618,168 L.L
L01BC01	ALEXAN	G	Cytarabine - 1,000mg/20ml	1,000mg/20ml	Injectable solution	L.L
A03BB01	SCOBUREN	G	Butylscopolamine bromide - 20mg/ml	20mg/ml	Injectable solution	370,901 L.L
B05AA01	ALBUTEIN	BioHuman	Albumin human - 20%	20%	Injectable solution	7,154,928 L.L
B05XA03	SERUFLEX SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	156,288 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 200mg	200mg	Injectable solution	123,001,362 L.L
L03AB07	RECIGEN 44	BioTech	Interferon beta-1a - 44mcg/0.5ml	44mcg/0.5ml	Injectable solution	15,147,973 L.L
N01BB58	ARTICAINE MEDIS ADRENALINE	G	Articaine HCl - 40mg/ml, Adrenaline - 0.07mg/ml		Injectable solution	1,881,380 L.L
N05CD08	MIDAZOLAM PANPHARMA	G	Midazolam - 5mg/5ml	5mg/5ml	Injectable solution	697,454 L.L
A03BB01	SCOPINAL	G	Butylscopolamine bromide - 20mg/ml	20mg/ml	Injectable solution	178,731 L.L
B05AA01	ALBUTEIN	BioHuman	Albumin human - 20%		Injectable solution	4,031,528 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	4,143,943 L.L
L03AB07	BLASTOFERON	BioTech	Interferon beta-1a - 22mcg	22mcg	Injectable solution	40,725,735 L.L
N01BB58	ORABLOC	G	Articaine HCl - 4%, Epinephrine (tartrate) - 1/100.000		Injectable solution	2,308,721 L.L
N05CD08	HIKMA MIDAZOLAM	G	Midazolam (HCl) - 5mg/ml	5mg/ml	Injectable solution	679,984 L.L
A03BB01	? HYOSCINE BUTYLBROMIDE	G	Hyoscine butylbromide - 20mg/ml	20mg/ml	Injectable solution	70,392 L.L
B05AA01	HUMAN ALBUMIN "OCTAPHARMA" 20%	BioHuman	Albumin human - 20%	20%	Injectable solution	4,863,366 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	3,985,356 L.L
L03AB07	AVONEX	BioTech	Interferon beta-1a - 30mcg/0.5ml	30mcg/0.5ml	Injectable solution	70,488,764 L.L
N05CD08	IPNODIS MEDIS	G	Midazolam - 5mg/ml	5mg/ml	Injectable solution	565,758 L.L
B05AA01	HUMAN ALBUMIN 20% SOLUTION	BioHuman	Albumin human - 20%	20%	Injectable solution	4,343,343 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	5,566,628 L.L
L03AB07	CINNOVEX	BioTech	Interferon beta-1a - 30mcg	30mcg	Injectable solution	39,804,728 L.L

...

195